参麦注射液治疗原发性肾病综合征的临床观察

Shenmai injection in the treatment of primary nephrotic syndrome

目的:探讨参麦注射液治疗原发性肾病综合征的临床疗效以及不良反应。方法:将93例原发性肾综合征病患者随机分为治疗组与对照组,两组均给予泼尼松和调节血脂、抗凝等基础治疗,治疗组给予联合参麦注射液。疗程16w。结果:治疗组24h尿蛋白定量、尿素氮、血肌酐、血脂、血浆白蛋白、泼尼松的用量、复发率等指标的改善明显优于对照组。结论:参麦注射液联合泼尼松、调节血脂、抗凝等治疗原发性肾病综合征的效果明显好于单纯泼尼松、调节血脂、抗凝等治疗的效果。

Objective:Shenmai injection to explore the treatment of primary nephrotic syndrome,as well as adverse reactions.Methods:93 cases of primary renal syndrome patients were randomly divided into treatment group and control group,two groups were given prednisone and regulation of blood lipids,and so on the basis of anticoagulant therapy,the treatment group were given a joint Shenmai injection,the control group not given Shenmai injection,treatment all 16 weeks.Results Treatment group, 24h urinary protein,blood urea nitrogen,serum creatinine,blood lipids,plasma albumin,Prednisone of dosage,the relapse rate of improvement in such indicators as better than the control group.Conclusion:Mr injection prednisone and regulating blood lipids, anticoagulant treatment of primary nephrotic syndrome,such as the effect of prednisone significantly better than simply to regulate blood lipids,anticoagulant,such as the effect of treatment.